Current Opinion in Endocrinology, Diabetes and Obesity

短名Curr. Opin. Endocrinol. Diabetes. Obes.
Journal Impact2.73
国际分区ENDOCRINOLOGY & METABOLISM(Q3)
期刊索引SCI Q3中科院 3 区
ISSN1752-296X, 1752-2978
h-index83
国内分区医学(3区)医学内分泌学与代谢(3区)

​​​​​​​​Current Opinion in Endocrinology, Diabetes and Obesity delivers a broad-based perspective on the most recent and exciting developments in the field from across the world. Published bimonthly and featuring twelve key topics – including androgens, gastrointestinal hormones, diabetes and the endocrine pancreas, and neuroendocrinology – the journal’s renowned team of guest editors ensure a balanced, expert assessment of the recently published literature in each respective field with insightful editorials and on-the-mark invited reviews.

期刊主页投稿网址
涉及主题医学生物内科学内分泌学遗传学化学病理生物化学糖尿病心理学激素
出版信息出版商: Lippincott Williams and Wilkins出版周期: 期刊类型: journal
基本数据创刊年份: 2007原创研究文献占比1.33%自引率:3.80%Gold OA占比: 14.72%
平均审稿周期 网友分享经验:较慢,6-12周

期刊引文格式

这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。

并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

以下是创作和编辑的书籍的参考文献的示例。

学位论文引用格式

网页引用格式

这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。

专利引用格式

最新文章

Male infertility and obesity

2024-9-10

Editorial introduction

2024-9-5

Time to cycle regularity and health risks

2024-9-2

Cardiometabolic risk factors in women: what's sauce for the goose is not sauce for the gander

2024-8-28

Testosterone and male contraception

2024-8-20

New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease

2024-8-2

Epidemiologic changes in thyroid disease

2024-8-2

TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease

2024-8-1

Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name?

2024-7-5

Advances in assessment and treatment of bone, mineral and parathyroid disorders

2024-6-25

Editorial introduction

2024-6-25

Update on fracture risk assessment in osteoporosis

2024-5-30

Insight into the potential of bone turnover biomarkers: integration in the management of osteoporosis and chronic kidney disease-associated osteoporosis

2024-5-28

The use of anabolic agents in the treatment of osteoporosis: a clinical update

2024-5-16

Hypoparathyroidism update

2024-5-16

Predictors of cardiovascular risk in familial hypercholesterolemia

2024-5-9

Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders

2024-4-30

The interaction between gut microbiome and bone health

2024-4-25

Editorial introduction

2024-4-23

Editorial overview

2024-4-23

Gut motility and hormone changes after bariatric procedures

2024-3-27

Gut hormones and appetite regulation

2024-3-21

Potassium-competitive acid blockers and acid-related disorders

2024-3-14

Addressing genetic and environmental sources of cardiometabolic disease

2024-2-29

Editorial introduction

2024-2-29

APOC3 siRNA and ASO therapy for dyslipidemia

2024-2-9

When history, law, and medicine intersect

2023-12-20

Editorial introductions

2023-12-20

Bempedoic acid: a new player for statin-intolerant patients and beyond

2023-12-14

Assessing the contribution of plastic-associated obesogenic compounds to cardiometabolic diseases

2023-12-6

Endocrine features of primary mitochondrial diseases

2023-12-4

Bone mass accrual in children

2023-11-27

Legislation, medicine, and politics: care for gender diverse youth

2023-11-27

Fibrous dysplasia in children and its management

2023-11-27

Multifactorial chylomicronemia syndrome

2023-11-24

Health economics of detection and treatment of children with familial hypercholesterolemia: to screen or not to screen is no longer the question

2023-11-20

Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia

2023-10-30

Addressing disparities in technology use among patients with type 1 diabetes: a review

2023-10-25

Editorial introductions

2023-10-24

Treating obesity in type 1 diabetes mellitus – review of efficacy and safety

2023-10-11

Integrating psychosocial and behavioral interventions into type 1 diabetes care

2023-10-6

Updates in thyroid healthcare delivery: advancing patient-centered care

2023-10-1

Assisted reproductive technology outcomes and management considerations for people with epilepsy

2023-9-21

A review of recent evidence on androgen abuse from interviews with users

2023-9-6

Editorial introductions

2023-9-6

Glucagon-like peptide-1 receptor agonists and safety in the preconception period

2023-9-5

Surveys on androgen abuse: a review of recent research

2023-8-21

Systematic reviews and meta-analyses on androgen administration in humans: an umbrella review

2023-8-21

Nutrition and thyroid disease

2023-8-13

Molecular testing for indeterminate thyroid nodules: past, present, and future

2023-8-2

帮你贴心管理全部的文献

研飞ivySCI,高效的论文管理

投稿经验分享

分享我的经验,帮你走得更远

Built withby Ivy Science
Copyright © 2020-2024
版权所有:南京青藤格致信息科技有限公司